A
AstraZeneca PLC (Cambridge, UK). 2024 revenue ~$50B. Oncology: Tagrisso, Enhertu (ADC). Rare disease: Alexion. Respiratory: Symbicort. API synthesis at Macclesfield, UK and Wuxi, China.
AstraZeneca
@astrazeneca
Joined July 2026
4 Following6 Followers